Abstract
The mitotic arrest deficient protein MAD2B is a well-defined anaphase-promoting complex/cyclosome (APC/C) inhibitor and a small subunit of DNA polymerase zeta. It is critical for mitotic control and DNA repair. However, the pathological role of MAD2B in kidney diseases has not been fully elucidated. In the present study, we aim to explore the role of MAD2B in the pathogenesis of renal tubulointerstitial fibrosis (TIF) and the underlying mechanism. By immunofluorescence and immunohistochemistry, we found an obvious MAD2B enhancement in tubular area of TIF patients and unilateral ureteral obstruction (UUO) mice. In vitro, transforming growth factor-β1 (TGF-β1) induced a time-dependent MAD2B accumulation prior to tubular epithelial-to-mesenchymal transition (EMT) in a rat proximal tubular epithelial cell line, NRK-52E. Knocking down MAD2B using siRNA dramatically inhibited TGF-β1-induced tubular EMT process and subsequent extracellular matrix (ECM) production. We also found that Skp2, a confirmed APC/C-CDH1 substrate and E-cadherin destroyer, was increased in TGF-β1-treated proximal tubular epithelial cells, which could be blocked by MAD2B depletion. In addition, Skp2 expression was also found to be increased in the renal tubular area of UUO mice. Locally knocking down MAD2B expression in the renal cortex using lentiviral transfection inhibited Skp2 expression, tubular EMT, and subsequent ECM accumulation. Taken together, our data suggests a pro-fibrotic role of MAD2B in the pathogenesis of tubular EMT and TIF by inducing Skp2 expression. MAD2B might be a potential target of promising interventions for renal TIF.
Key messages
-
Renal fibrosis activates MAD2B expression in renal tubules of human and mouse.
-
TGF-β1 contributes to MAD2B enhancement in rat tubular epithelial cells.
-
MAD2B depletion alleviates renal tubulointerstitial fibrosis in vivo and in vitro.
-
MAD2B promotes EMT transition in rat tubular epithelial cells by inducing Skp2.
Similar content being viewed by others
References
Liu Y (2011) Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7(12):684–696
Sharma SK, Zou H, Togtokh A, Ene-Iordache B, Carminati S, Remuzzi A, Wiebe N, Ayyalasomayajula B, Perico N, Remuzzi G (2010) Burden of CKD, proteinuria, and cardiovascular risk among Chinese, Mongolian, and Nepalese participants in the International Society of Nephrology screening programs. Am J Kidney Dis 56(5):915–927
Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379(9818):815–822
Meng XM, Tang PM, Li J, Lan HY (2015) TGF-beta/Smad signaling in renal fibrosis. Front Physiol 6:82
Petersen M, Thorikay M, Deckers M, van Dinther M, Grygielko ET, Gellibert F, de Gouville AC, Huet S, ten Dijke P, Laping NJ (2008) Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis. Kidney Int 73(6):705–715
Moon JA, Kim HT, Cho IS, Sheen YY, Kim DK (2006) IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int 70(7):1234–1243
Laney JD, Hochstrasser M (1999) Substrate targeting in the ubiquitin system. Cell 97(4):427–430
Jonathon P (2011) Cubism and the cell cycle: the many faces of the APC/C. Nat Rev Mol Cell Bio 12(7):533
Wan Y, Liu X, Kirschner MW (2001) The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction. Mol Cell 8(5):1027–1039
Zhang L, Fujita T, Wu G, Xiao X, Wan Y (2011) Phosphorylation of the anaphase-promoting complex/Cdc27 is involved in TGF-beta signaling. J Biol Chem 286(12):10041–10050
Cahill DP, da Costa LT, Carson-Walter EB, Kinzler KW, Vogelstein B, Lengauer C (1999) Characterization of MAD2B and other mitotic spindle checkpoint genes. Genomics 58(2):181–187
Doerks T, Copley RR, Schultz J, Ponting CP, Bork P (2002) Systematic identification of novel protein domain families associated with nuclear functions. Genome Res 12(1):47–56
Listovsky T, Sale JE (2013) Sequestration of CDH1 by MAD2L2 prevents premature APC/C activation prior to anaphase onset. J Cell Biol 203(1):87–100
Xu G, Chapman JR, Brandsma I, Yuan J, Mistrik M, Bouwman P, Bartkova J, Gogola E, Warmerdam D, Barazas M et al (2015) REV7 counteracts DNA double-strand break resection and affects PARP inhibition. Nature 521(7553):541–544
Rimkus C, Friederichs J, Rosenberg R, Holzmann B, Siewert JR, Janssen KP (2007) Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer. Int J Cancer 120(1):207–211
Niimi K, Murakumo Y, Watanabe N, Kato T, Mii S, Enomoto A, Asai M, Asai N, Yamamoto E, Kajiyama H et al (2014) Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells. Cancer Sci 105(5):545–552
Zhao J, Liu S, Wang H, Zhang X, Kang T, Li Z, Deng H, Yue W, Cao S (2011) Mitotic arrest deficient protein MAD2B is overexpressed in human glioma, with depletion enhancing sensitivity to ionizing radiation. J Clin Neurosci 18(6):827–833
Su H, Wan Q, Tian XJ, He FF, Gao P, Tang H, Ye C, Fan D, Chen S, Wang YM et al (2015) MAD2B contributes to podocyte injury of diabetic nephropathy via inducing cyclin B1 and Skp2 accumulation. Am J Physiol Renal Physiol 308(7):F728–F736
Wang YM, Hao Y, Meng XF, He FF, Chen S, Gao P, Tang H, Su H, Zhang C (2015) Attenuation of glomerular endothelial cells from high glucose-induced injury by blockade of MAD2B. Cell Physiol Biochem 35(1):61–70
Fukasawa H, Yamamoto T, Togawa A, Ohashi N, Fujigaki Y, Oda T, Uchida C, Kitagawa K, Hattori T, Suzuki S et al (2004) Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci U S A 101(23):8687–8692
Kim M, Chen SW, Park SW, Kim M, D’Agati VD, Yang J, Lee HT (2009) Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury. Kidney Int 75(8):809–823
Hao S, Bellner L, Ferreri NR (2013) NKCC2A and NFAT5 regulate renal TNF production induced by hypertonic NaCl intake. Am J Physiol Renal Physiol 304(5):F533–F542
Junqueira LC, Bignolas G, Brentani RR (1979) Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11(4):447–455
Gao P, Meng XF, Su H, He FF, Chen S, Tang H, Tian XJ, Fan D, Wang YM, Liu JS et al (2014) Thioredoxin-interacting protein mediates NALP3 inflammasome activation in podocytes during diabetic nephropathy. Biochim Biophys Acta 1843(11):2448–2460
Zhang H (2010) Skip the nucleus, AKT drives Skp2 and FOXO1 to the same place? Cell Cycle 9(5):868–869
Meng X, Wang X, Tian X, Yang Z, Li M, Zhang C (2014) Protection of neurons from high glucose-induced injury by deletion of MAD2B. J Cell Mol Med 18(5):844–851
Chérif B, Alexis D, Daniela B, Aoumeur HA, Brigitte MG, Nicole L, Jean Louis T, Maurice L (2002) Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction. Nephrol Dial Transpl 17(11):1993–1998
Mack M, Yanagita M (2015) Origin of myofibroblasts and cellular events triggering fibrosis. Kidney Int 87(2):297–307
Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG (1995) Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130(2):393–405
Junwei Y, Youhua L (2002) Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13(13):96–107
Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, Nikolic-Paterson DJ, Atkins RC, Lan HY (1998) Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 54(3):864–876
Gonzalez DM, Medici D (2014) Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal 7 (344):re8. doi:10.1126/scisignal.2005189
Barriere G, Fici P, Gallerani G, Fabbri F, Rigaud M (2015) Epithelial mesenchymal transition: a double-edged sword. Clin Transl Med 4:14
Chen J, Fang G (2001) MAD2B is an inhibitor of the anaphase-promoting complex. Genes Dev 15(14):1765–1770
Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M (2004) Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 428(6979):190–193
Gao D, Inuzuka H, Tseng A, Chin RY, Toker A, Wei W (2009) Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat Cell Biol 11(4):397–408
Qu X, Shen L, Zheng Y, Cui Y, Feng Z, Liu F, Liu J (2014) A signal transduction pathway from TGF-beta1 to SKP2 via Akt1 and c-Myc and its correlation with progression in human melanoma. J Invest Dermatol 134(1):159–167
Suzuki S, Fukasawa H, Misaki T, Togawa A, Ohashi N, Kitagawa K, Kotake Y, Niida H, Hishida A, Yamamoto T et al (2011) Up-regulation of Cks1 and Skp2 with TNFalpha/NF-kappaB signaling in chronic progressive nephropathy. Genes Cells 16(11):1110–1120
Suzuki S, Fukasawa H, Kitagawa K, Uchida C, Hattori T, Isobe T, Oda T, Misaki T, Ohashi N, Nakayama K et al (2007) Renal damage in obstructive nephropathy is decreased in Skp2-deficient mice. Am J Pathol 171(2):473–483
Eddy AA (2014) Overview of the cellular and molecular basis of kidney fibrosis. Kidney Int Suppl (2011) 4(1):2–8
Inuzuka H, Gao D, Finley LW, Yang W, Wan L, Fukushima H, Chin YR, Zhai B, Shaik S, Lau AW et al (2012) Acetylation-dependent regulation of Skp2 function. Cell 150(1):179–193
Yang Q, Huang J, Wu Q, Cai Y, Zhu L, Lu X, Chen S, Chen C, Wang Z (2014) Acquisition of epithelial-mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells. Br J Cancer 110(8):1958–1967
Acknowledgments
This work was supported by grants from the National Natural Science Foundation of China (No. 81170662, No. 31200872, No. 81470964, No. 81570671, No. 81471490, and No. 81522010), a grant from the Wuhan Science and Technology Bureau (No. 2015060101010039), and a Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20130142110064).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The use of parts of mouse kidney biopsies and human renal biopsies for research purposes was approved by the Ethics Committee of Huazhong University of Science and Technology. Animals were treated humanely, and all the procedures were performed according to the guidelines for use and care of laboratory animals of National Institutes of Health (NIH), and approved by the Animal Care and Use Committee (ACUC) of Tongji Medical College.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Tang, H., Fan, D., Lei, CT. et al. MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2. J Mol Med 94, 1297–1307 (2016). https://doi.org/10.1007/s00109-016-1448-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-016-1448-6